glp-1 prescriptions growth q1 2025 Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline GLP-1 Users: Trends on Long-Term

ColonBroom highlights non-GMO sourcing, vegan-friendly capsules, and cGMP-certified facilities

Patients should contact their healthcare provider promptly if they experience severe abdominal pain, persistent nausea and vomiting, signs of pancreatitis, or any concerning symptoms

10.1136/gutjnl-2021-326789 29 DoyleM

The active peptide structure breaks down when exposed to temperatures above 46F, potentially rendering your dose less potent or unsafe

This yielded a risk difference of 0.3% (95% CI 0.6% to 0.04%) and an HR of 0.87 (95% CI 0.75 to 1.01) (Fig

But experts say such Canadian rules are a crucial bulwark against a deluge of marketing messages that do not put patient safety first